Diabetic autonomic neuropathy: What are the risks?

Authors
Citation
P. Valensi, Diabetic autonomic neuropathy: What are the risks?, DIABETE MET, 24, 1998, pp. 66-72
Citations number
54
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
DIABETES & METABOLISM
ISSN journal
12623636 → ACNP
Volume
24
Year of publication
1998
Supplement
3
Pages
66 - 72
Database
ISI
SICI code
1262-3636(199811)24:<66:DANWAT>2.0.ZU;2-2
Abstract
This paper considers the risks related to each of the complications of diab etic autonomic neuropathy. Gastroparesia induces its own functional disorde rs in the digestive tract but is also probably involved in an undetermined proportion of unstable diabetes. Neural bladder, in its aspect of hypoactiv e, hypocontractile and hypoaesthesic bladder, makes patients prone to urina ry chronic retention and repeated urinary infections or even kidney disease . In patients with hypoglycaemia unawareness, the responsibility of autonom ic neuropathy may he suspected in those with severe cardiac autonomic neuro pathy (CAN) or selective autonomic neuropathy characterised only by a defec t in adrenergic contraregulation of hypoglycaemia. CAN is the best-known an d most frequent complication of dysautonomia; Several longitudinal studies have clearly shown that CAN is associated with excessive mortality. Various functional disorders may account for the increased frequency of cardiovasc ular events. In particular, a reduction of left ventricle ejection fraction , inadaptability of haemodynamic response to exercise, alterations of the n ycthemeral pattern of blood pressure variations, ventricle repolarisation a nd ventilatory function have been associated with CAN. Though the relations hip between CAN and silent myocardial ischaemia is not clearly established, CAN seems to increase the frequency of major cardiac events, particularly in patients with silent myocardial ischaemia. Vascular neuropathy, by alter ing peripheral vasomotricity, may contribute to foot ulcer. The statistical association between CAN and retinopathy and kidney disease suggests that C AN might contribute to worsening microangiopathic complications or at least be considered as a marker of these complications. Finally, several argumen ts suggest an association between CAN and insulin resistance. Thus CAN migh t be involved in the poor prognosis of kidney disease or insulin resistance . From a practical point of view, the risks related to diabetic dysautonomi a, which range from simple discomfort to severe complications, should lead to systematic detection of dysautonomia. In any event, detection by standar dised tests analysing heart rate variations should he widely performed, and the presence of CAN should lead to a specific cardiovascular assessment.